Evidence map›Paper›PMID 27055915›Full record

ReviewBrain research2016

Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.

Benjamin L L Clayton, Brian Popko

Open access · greenAbstract readReview
In one paragraph

Review in Brain research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Expanding theNeurology. Genetics · 2026
    Article
  5. Review
  6. Article
  7. Myelin-Proteinoids Interactions in Neural Signaling.Langmuir : the ACS journal of surfaces and colloids · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Alexander disease: the road ahead.Neural regeneration research · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Mechanisms and Treatments in Demyelinating CMT.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Benjamin L L ClaytonDepartment of Neurology, The University of Chicago Center for Peripheral Neuropathy, The University of Chicago, IL 60637, United States.
Brian PopkoDepartment of Neurology, The University of Chicago Center for Peripheral Neuropathy, The University of Chicago, IL 60637, United States. Electronic address: bpopko@neurology.bsd.uchicago.edu.
University of Chicago · US

Funding

Targeting the integrated stress response to protect oligodendrocyte lineage cells - Resubmission 01R01NS034939 · NINDS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI POPKO, BRIAN J · 1997 to 2024
$7.5M
NINDS NIH HHS R01 NS034939
6 · The paper itself

Abstract

Myelin is vital to the proper function of the nervous system. Oligodendrocytes in the CNS and Schwann cells in the PNS are the glial cells responsible for generating the myelin sheath. Myelination requires the production of a vast amount of proteins and lipid-rich membrane, which puts a heavy load on the secretory pathway of myelinating glia and leaves them susceptible to endoplasmic reticulum (ER) stress. Cells respond to ER stress by activating the unfolded protein response (UPR). The UPR is initially protective but in situations of prolonged unresolved stress the UPR can lead to the apoptotic death of the stressed cell. There is strong evidence that ER stress and the UPR play a role in a number of disorders of myelin and myelinating glia, including multiple sclerosis, Pelizaeus-Merzbacher disease, Vanishing White Matter Disease, and Charcot-Marie-Tooth disease. In this review we discuss the role that ER stress and the UPR play in these disorders of myelin. In addition, we discuss the progress that has been made in our understanding of the effect genetic and pharmacological manipulation of the UPR has in mouse models of these disorders and the novel therapeutic potential of targeting the UPR that these studies support. This article is part of a Special Issue entitled SI:ER stress.

Indexed as

Adrenergic alpha-2 Receptor AgonistsAnimalsDemyelinating DiseasesEndoplasmic Reticulum StressGuanabenzHumansNeurogliaUnfolded Protein ResponseAdrenergic alpha-2 Receptor AgonistsGuanabenzsephin1ER stressMyelinOligodendrocytesSchwann cellsUnfolded protein response

Identifiers

PMID27055915
PMCPMC5036997
OpenAlexW2322763135

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.